Zimpfer Matthew J. 4/A
4/A · CNO Financial Group, Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4/AAmended
Zimpfer Matthew J.
General Counsel
Transactions
- Sale
Common Stock
2025-02-21$40.10/sh−40,800$1,636,284→ 285,743 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-02-21−40,800→ 0 totalExercise: $17.38Exp: 2026-02-23→ Common Stock (40,800 underlying) - Exercise/Conversion
Common Stock
2025-02-19$17.38/sh+40,800$709,104→ 326,543 total - Sale
Common Stock
2025-02-19$41.49/sh−40,800$1,692,898→ 285,743 total - Exercise/Conversion
Common Stock
2025-02-21$17.38/sh+40,800$709,104→ 326,543 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-02-19−40,800→ 40,800 totalExercise: $17.38Exp: 2026-02-23→ Common Stock (81,600 underlying)
Footnotes (5)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan adopted on August 23, 2024.
- [F2]Reflects the weighted average sale price. Shares were sold at prices ranging from $41.20 per share to $41.80 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
- [F3]Reflects the weighted average sale price. Shares were sold at prices ranging from $39.66 per share to $41.00 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
- [F4]This amendment corrects (i) the presentation of the exercise of stock options and (ii) the amount of securities beneficially owned following the transactions.
- [F5]One-half of the stock options vested on February 23, 2018, and one-half vested on February 23, 2019.